Literature DB >> 33380914

Modern Management of Facial Nerve Disorders.

Tom Shokri1, Babak Azizzadeh2,3, Yadranko Ducic1.   

Abstract

Facial paralysis is a devastating condition, encompassing a spectrum of disorders, with resultant psychosocial, functional, and aesthetic sequelae. With this in mind, an individualized treatment approach based on the cause, pattern, and duration of palsy is necessary. Treatment options include pharmacologic agents, corneal protective interventions, physical therapy, and surgical procedures. The use of steroids and antivirals in the setting of idiopathic facial paralysis or virus-associated facial paralysis is well supported. Despite the diversity of surgical interventions described, there is a lack of consensus regarding optimal treatment. This article provides an overview of the current management of facial paralysis. Medical, surgical, and physical treatment options are discussed with a review of the relevant literature. Thieme. All rights reserved.

Entities:  

Keywords:  botulinum toxin; facial paralysis; facial reanimation; modified selective neurectomy; smile dysfunction; synkinesis

Year:  2020        PMID: 33380914      PMCID: PMC7759435          DOI: 10.1055/s-0040-1721824

Source DB:  PubMed          Journal:  Semin Plast Surg        ISSN: 1535-2188            Impact factor:   2.314


  2 in total

1.  Efficacy and Safety of Pharmacological and Physical Therapies for Bell's Palsy: A Bayesian Network Meta-Analysis.

Authors:  Jianwei Shi; Dafeng Lu; Hairong Chen; Mingzhu Shu; Yang Xu; Jiaojiao Qian; Ke Ouyang; Huaying Huang; Zhengxiang Luo; Chunhui Wang; Yansong Zhang
Journal:  Front Neurol       Date:  2022-04-18       Impact factor: 4.086

2.  Using High-Resolution Ultrasound to Assess Post-Facial Paralysis Synkinesis-Machine Settings and Technical Aspects for Facial Surgeons.

Authors:  Andreas Kehrer; Marc Ruewe; Natascha Platz Batista da Silva; Daniel Lonic; Paul Immanuel Heidekrueger; Samuel Knoedler; Ernst Michael Jung; Lukas Prantl; Leonard Knoedler
Journal:  Diagnostics (Basel)       Date:  2022-07-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.